Have a personal or library account? Click to login
Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors Cover

Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors

Acta Pharmaceutica
Volume 72 (2022): Issue 1 (March 2022)
By: Cyril Fersing and  Fanny Mathias  
Open Access
|Aug 2021

Authors

Cyril Fersing

cyril.fersing@icm.unicancer.fr

University of Montpellier, Montpellier Cancer Institute (ICM), Montpellier, France
Institut des Biomolécules Max Mousseron UMR 5247, CNRS, Université de Montpellier ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, France

Fanny Mathias

Aix Marseille Univ, Pharmacy Department Hôpital Nord, Assistance Publique Hôpitaux de Marseille, Marseille, France
Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire Faculté de Pharmacie, France
DOI: https://doi.org/10.2478/acph-2022-0007 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 9 - 34
Accepted on: Jan 26, 2021
Published on: Aug 30, 2021
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
glasdegib,
PF-04449913,
PF-913,
acute myeloid leukemia,
Hedgehog pathway,
smoothened
Related subjects:
Pharmacy,
Pharmacy, other

© 2021 Cyril Fersing, Fanny Mathias, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 72 (2022): Issue 1 (March 2022)Next article